Bolt Biotherapeutics (BOLT) — Financial Flexibility Index
Bolt Biotherapeutics (BOLT) has a Financial Flexibility Index of -0.24x as of December 2025. Free cash flow of $-7.16 Million (operating CF $-7.16 Million minus capex $0.00) represents 0% of total liabilities ($30.24 Million). Also explore BOLT year-over-year net asset growth to track the company's year-over-year net asset growth rate.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Bolt Biotherapeutics Financial Flexibility Index (2018–2025)
Historical Financial Flexibility Index trend for Bolt Biotherapeutics across 8 annual periods. Check Bolt Biotherapeutics PP&E and investment ratio to assess the company's strategic physical and investment asset allocation.
Annual Financial Flexibility Index for Bolt Biotherapeutics (2018–2025)
Year-by-year free cash flow to debt coverage for Bolt Biotherapeutics. For the full company profile including market capitalisation, see BOLT market cap overview.
| Year | Flexibility Index | Free Cash Flow (USD) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2025 | -1.32x | $-39.78 Million | $-39.85 Million | $30.24 Million | ▲ +8.9% |
| 2024 | -1.44x | $-61.25 Million | $-61.29 Million | $42.43 Million | ▲ +2.0% |
| 2023 | -1.47x | $-69.32 Million | $-69.53 Million | $47.04 Million | ▼ -11.3% |
| 2022 | -1.32x | $-74.55 Million | $-76.50 Million | $56.30 Million | ▼ -39.4% |
| 2021 | -0.95x | $-54.73 Million | $-57.07 Million | $57.60 Million | ▼ -226.8% |
| 2020 | -0.29x | $-44.05 Million | $-47.31 Million | $151.49 Million | ▼ -6.1% |
| 2019 | -0.27x | $-25.84 Million | $-26.34 Million | $94.29 Million | ▲ +8.7% |
| 2018 | -0.30x | $-9.58 Million | $-9.87 Million | $31.92 Million | — |